PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsLeiomyosarcoma
MeSH D007890 - leiomyosarcoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009379:Muscle tissue neoplasms
0 Companies
0 Drugs
Success rate
D012509:Sarcoma
$
Success rate
D007890: 
Leiomyosarcoma
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Johnson & JohnsonTrabectedin Yondelis 2028-01-07 2015-10-23   
Pharma MarTrabectedin Yondelis  2007-09-17   
Clinical Trials
Historical Success Rate
Phase 1
87%
13/15
Phase 2
24%
13/54
Phase 3
13%
2/15
Approved: 1Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Johnson & Johnson
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use